News of Note—APAC adds 50 jobs at Virginia site; New sterile injectable CMO forms

stock market
(Pixabay)

 

> China's WuXi Biologics says it is adding commercial manufacturing to the integrated biologics conjugation solution center it is building in Wuxi, China. Release

> Two U.K. contract manufacturers, Cobra Biologics and Symbiosis Pharmaceutical Services, have invested £4.8 million in a collaboration on viral vector manufacturing. Release 

> After making upgrades, API maker AMPAC Fine Chemicals has reopened a plant in Petersburg, Virginia, that has a 50,000-gallon capacity and will add 150 jobs. Release 

Free Webinar

Striving for Zero in Quality & Manufacturing

Pharmaceutical and medical device manufacturers strive towards a culture of zero – zero hazards, zero defects, and zero waste. This webinar will discuss the role that content management plays in pharmaceutical manufacturing to help companies reach the goal of zero in Quality and Manufacturing.

> A new CMO has come on the scene with plans to build a $30 million sterile drug manufacturing facility on the West Coast. Story

Read more on

Suggested Articles

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Continuing its expansion efforts, Japan’s Fujifilm will make a major investment in its U.S. gene therapy operation in Texas.